accountFluzone Intradermal vaccine, licensed by the U.S. Food and Drug Administration (FDA), is claimed to be the first influenza vaccine in the U.S. that uses a microinjection system for intradermal delivery.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Sanofi Pasteur’s New Influenza Vaccine
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account